These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 30763

  • 21. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [Abstract] [Full Text] [Related]

  • 22. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ, McDermott CM.
    Pharmatherapeutica; 1983 Jul; 3(7):451-5. PubMed ID: 6142462
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L, Bienfait J, Dethier J, Even P, Evrard JL, Fraipont J, Goffin L, Willemse P.
    Acta Psychiatr Belg; 1981 Jul; 81(6):595-608. PubMed ID: 6125089
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [Abstract] [Full Text] [Related]

  • 27. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.
    J Clin Psychiatry; 1997 Jan; 58 Suppl 11():19-23. PubMed ID: 9363044
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
    Samuelian JC, Billardon M, Guillou N.
    Encephale; 1995 Jan; 21(2):147-53. PubMed ID: 7781586
    [Abstract] [Full Text] [Related]

  • 31. Clinical profile of lorazepam, a new benzodiazepine tranquilizer.
    Richards DJ.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):58-66. PubMed ID: 30770
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [Abstract] [Full Text] [Related]

  • 34. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D, Hill C, Lenderking W, Williams V, Morlock R.
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [Abstract] [Full Text] [Related]

  • 35. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I, Colombo G, Furlanut M, Benetello P.
    Int J Clin Pharmacol Res; 1989 Oct; 9(3):203-8. PubMed ID: 2568350
    [Abstract] [Full Text] [Related]

  • 36. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V, Beszterczy A, Geagea C.
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract] [Full Text] [Related]

  • 37. Lorazepam, a new benzodiazepine derivative, in the treatment of anxiety: a double-blind clinical evaluation.
    McCurdy L.
    Am J Psychiatry; 1979 Feb; 136(2):187-90. PubMed ID: 32776
    [Abstract] [Full Text] [Related]

  • 38. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [Abstract] [Full Text] [Related]

  • 39. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [Abstract] [Full Text] [Related]

  • 40. Buspirone: multicenter efficacy study.
    Wheatley D.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.